Current and historical daily PE Ratio for BioGaia AB (
) from 2013 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. BioGaia AB stock (BIOGY) PE ratio as of Jun 09 2024 is 33.98.
More Details
BioGaia AB (BIOGY) PE Ratio (TTM) Chart
BioGaia AB (BIOGY) PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Total 1244
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| BioGaia AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 34.9 | 2024-04-05 | 34.9 |
| 2024-06-07 | 34.9 | 2024-04-04 | 34.9 |
| 2024-06-06 | 34.9 | 2024-04-03 | 34.9 |
| 2024-06-05 | 34.9 | 2024-04-02 | 34.9 |
| 2024-06-04 | 34.9 | 2024-04-01 | 34.9 |
| 2024-06-03 | 34.9 | 2024-03-28 | 34.9 |
| 2024-05-31 | 34.9 | 2024-03-27 | 35.6 |
| 2024-05-30 | 34.9 | 2024-03-26 | 35.6 |
| 2024-05-29 | 33.9 | 2024-03-25 | 35.6 |
| 2024-05-28 | 33.9 | 2024-03-22 | 35.6 |
| 2024-05-24 | 33.2 | 2024-03-21 | 35.6 |
| 2024-05-23 | 33.2 | 2024-03-20 | 35.6 |
| 2024-05-22 | 33.2 | 2024-03-19 | 32.7 |
| 2024-05-21 | 33.2 | 2024-03-18 | 32.7 |
| 2024-05-20 | 33.2 | 2024-03-15 | 32.7 |
| 2024-05-17 | 33.2 | 2024-03-14 | 30.1 |
| 2024-05-16 | 33.2 | 2024-03-13 | 30.1 |
| 2024-05-15 | 33.2 | 2024-03-12 | 30.1 |
| 2024-05-14 | 33.2 | 2024-03-11 | 30.1 |
| 2024-05-13 | 33.2 | 2024-03-08 | 30.1 |
| 2024-05-10 | 33.2 | 2024-03-07 | 30.1 |
| 2024-05-09 | 33.2 | 2024-03-06 | 30.1 |
| 2024-05-08 | 33.2 | 2024-03-05 | 30.1 |
| 2024-05-07 | 33.2 | 2024-03-04 | 30.1 |
| 2024-05-06 | 28.1 | 2024-03-01 | 30.1 |
| 2024-05-03 | 28.1 | 2024-02-29 | 30.1 |
| 2024-05-02 | 28.1 | 2024-02-28 | 30.1 |
| 2024-05-01 | 28.1 | 2024-02-27 | 30.1 |
| 2024-04-30 | 28.1 | 2024-02-26 | 30.1 |
| 2024-04-29 | 28.1 | 2024-02-23 | 30.1 |
| 2024-04-26 | 28.1 | 2024-02-22 | 30.1 |
| 2024-04-25 | 28.1 | 2024-02-21 | 30.1 |
| 2024-04-24 | 28.1 | 2024-02-20 | 30.1 |
| 2024-04-23 | 28.1 | 2024-02-16 | 30.1 |
| 2024-04-22 | 28.1 | 2024-02-15 | 30.1 |
| 2024-04-19 | 28.1 | 2024-02-14 | 30.1 |
| 2024-04-18 | 28.1 | 2024-02-13 | 30.1 |
| 2024-04-17 | 34.9 | 2024-02-12 | 30.1 |
| 2024-04-16 | 34.9 | 2024-02-09 | 30.1 |
| 2024-04-15 | 34.9 | 2024-02-08 | 30.1 |
| 2024-04-12 | 34.9 | 2024-02-07 | 30.1 |
| 2024-04-11 | 34.9 | 2024-02-06 | 30.1 |
| 2024-04-10 | 34.9 | 2024-02-05 | 30.1 |
| 2024-04-09 | 34.9 | 2024-02-02 | 30.1 |
| 2024-04-08 | 34.9 | 2024-02-01 | 30.1 |
BioGaia AB (BIOGY) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
BioGaia AB
ISIN : US09072J1025
Share Class Description:
BIOGY: ADRCompare
Compare
Traded in other countries / regions
BIOG B.Sweden0GTN.UKBIOGY.USABGLA.Germany IPO Date
2013-04-03Description
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers